CIK 0001782223
- Emerging growth company
Pyxis Oncology, Inc.
Sign in to watch- Ticker
- PYXS
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 831160910
- Phone
- +1 617-221-9059
- Business address
- 321 HARRISON AVENUE, BOSTON, MA, 02118
- Open-market buys, last 90 days
- $0
- in 1 filing
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-03-24 | Wadhane Jitendra Prin Fin & Acct Officer | Grant or award | +109,461 | 512,882 | ||
| 2026-03-24 | Wadhane Jitendra Prin Fin & Acct Officer | Grant or award · Stock Option (Right to Buy) | +262,635 | 262,635 | ||
| 2025-03-31 | Wadhane Jitendra SVP, Chief Accounting Officer | Grant or award · Stock Option (Right to Buy) | +263,782 | $0.98 | $259K | 263,782 |
| 2024-12-23 | Wadhane Jitendra SVP, Chief Accounting Officer | Grant or award · Stock Option (Right to Buy) | +150,000 | 150,000 | ||
| 2024-03-26 | Wadhane Jitendra SVP, Chief Accounting Officer | Grant or award | +131,484 | 398,421 | ||
| 2023-11-15 | Wadhane Jitendra Chief Accounting Officer | Grant or award | +40,000 | 266,937 | ||
| 2023-09-27 | Wadhane Jitendra Chief Accounting Officer | Purchase | +2,500 | $1.87 | $5K | 226,937 |
| 2023-09-25 | Wadhane Jitendra Chief Accounting Officer | Purchase | +5,000 | $1.77 | $9K | 224,437 |
| 2023-09-22 | Wadhane Jitendra Chief Accounting Officer | Purchase | +2,500 | $1.74 | $4K | 219,437 |
| 2023-09-07 | Wadhane Jitendra Chief Accounting Officer | Grant or award | +93,896 | 211,937 | ||
| 2023-03-24 | Wadhane Jitendra Chief Accounting Officer | Grant or award | +29,393 | 118,041 | ||
| 2023-03-24 | Wadhane Jitendra Chief Accounting Officer | Grant or award | +45,000 | 88,648 | ||
| 2023-03-24 | Wadhane Jitendra Chief Accounting Officer | Returned to the company · Stock Option (Right to buy) | −157,257 | 0 | ||
| 2023-03-24 | Wadhane Jitendra Chief Accounting Officer | Grant or award · Stock Option (Right to buy) | +157,257 | 157,257 |
Page 1 of 1 · 14 trades